This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
5mg | $200 | 3-6 Days |
10mg | $350 | 3-6 Days |
25mg | $650 | 3-6 Days |
50mg | $1050 | 3-6 Days |
Cat #: V42057 CAS #: 2291360-73-9 Purity ≥ 99%
Description: NVP-DKY709 (NVP-DKY-709; DKY-709) is a first-in-class selective cereblon (CRBN) glue degrader of IKZF2 with anticancer and may be used for cancer immunotherapy. It spares IKZF1 and IKZF3 from degradation. X-ray crystal structure of IKZF2 zinc fingers bound to DDB1:CRBN:NVP-DKY709 explained the target selectivity of NVP-DKY709. In vitro, NVP-DKY709 modulated Treg cell and Teff cell functions. In a mouse breast cancer xenograft model, daily oral dosing with NVP-DKY709 led to degradation of IKZF2 in tumour and peripheral blood Treg cells, reducing tumour growth similarly to that achieved with the anti-PD1 antibody PDR001. Oral NVP-DKY709 effectively degraded IKZF2 in monkeys and patients and is currently being evaluated in a first-in-human phase I trial in solid tumours.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Formula | C25H27N3O3 |
---|---|
CAS No. | 2291360-73-9 |
SMILES Code | O=C1C2=CC=C(C=C2CN1C1CCC(=O)NC1=O)C1CCN(CC2C=CC=CC=2)CC1 |
Synonyms | NVP-DKY709; DKY-709; NVP-DKY-709; DKY 709;NVP-DKY 709; DKY709 |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.